4//SEC Filing
Cheng Sohanya Roshan 4
Accession 0001209191-23-048159
CIK 0001503802other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:27 PM ET
Size
5.1 KB
Accession
0001209191-23-048159
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-09-01$1.33/sh−7,415$9,872→ 204,086 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001865796
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:27 PM ET
- Size
- 5.1 KB